UNTOUCHED Trial Shows Low Complication Rate With Boston Scientific’s Emblem S-ICD

[Editor's note:Complete historical information on important medical device trial announcements is available from Informa’s Meddevicetracker. For an archive of previous Medtech Insight articles on medtech clinical trials, visit the Clinical Trials page.]

Results of the UNTOUCHED trial of Boston Scientific Corp.’s Emblem subcutaneous implantable cardioverter defibrillator (S-ICD) showed complication and arrhythmia-conversion rates comparable to those seen in earlier S-ICD trials...